Does Dr. ABDUR REHMAN AQEEL have financial conflicts of interest?

Dr. ABDUR REHMAN AQEEL (MD) has received a total of $120 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $120 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ABDUR REHMAN AQEEL?

According to CMS Open Payments data, Dr. ABDUR REHMAN AQEEL received funding from SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US ($55), ABIOMED ($51), and SMITH+NEPHEW ($14).

Does Dr. ABDUR REHMAN AQEEL receive research grants or speaking fees?

Dr. ABDUR REHMAN AQEEL has received $120 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ABDUR REHMAN AQEEL

MDReal-Time Hydrated

Specialty: Family Medicine

Practice Location: WACO, TX 76712

NPI Number: 1962069187

LIFETIME INDUSTRY VALUE

$120

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AQEEL is a verified Family Medicine practitioner based in WACO, TX.

Between 2021 and 2025, Dr. AQEEL had an overall industry promotional and research financial footprint of $120 as recorded in the federal CMS Open Payments database.

$120 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AQEEL's primary funding source is SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, which accounts for $55 (representing 46.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US

Rank 1

$55

46.2%

ABIOMED

Rank 2

$51

42.3%

SMITH+NEPHEW

Rank 3

$14

11.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.